Siris Medical empowers clinicians to achieve efficient high-quality cancer treatment decisions.
Siris Medical empowers clinicians to achieve efficient high-quality cancer treatment decisions. It has commercialized the first FDA 510(k) cleared artificial intelligence decision support platform in radiation oncology. It is a member of both the North Shore InnoVentures and the UCSF / QB3 Rosenman incubation programs.
Announced Date | Round | Money Raised | Number of Investors | Lead Investors | Post Valuation | |
---|---|---|---|---|---|---|
Sep 19, 2017 | Series A | $4M | 1 | Medical Technology Venture Partners | — | Detail |
Investor Name | Lead Investor | Funding Round |
---|---|---|
Medical Technology Venture Partners | Yes | Series A |